Even if retracted, published clinical trial reports that misrepresent findings, withhold negative data, or make false, or unsubstantiated claims have done irreparable damage. AHRP calls upon all medical journals to adopt a publication policy requiring submission of the sponsor’s formal Clinical Study Report to accompany articles about clinical trial findings.
Even as the corruption of science is no longer a dirty little secret, but is in plain sight, no one is doing anything tostop it. April 16, 2012 A Sharp Rise in Retractions Prompts Calls for Reform By CARL ZIMMER In the fall of 2010, Dr. Ferric C. Fang…
Project on Government Oversight (POGO) asked NIH Director to take a firm stance against ghostwriting by academics who receive taxpayer funded grants.
“To ghostwrite an entire textbook is a new level of chutzpah,” said Dr. David A. Kessler, former commissioner of the Food and Drug Administration, after reviewing the documents. “I’ve never heard of that before. It takes your breath away.”
"What’s gone on with the pharmaceutical industry is a physician arms race to buy off doctors…"
The dust-up involving Dr. Charles Nemeroff and Dr. Thomas Insell, director of NIMH shines a light on NIH leaders whose failure to enforce federal disclosure requirements is brushed off with excuses so untenable they have the ring of theater of the absurd.
"Dr. Nemeroff has become the poster child for what’s wrong with academic medicine in our country." Dr. Thomas Insell, Director of the NIMH, quietly helped him get a prized position at the University of Miami.
The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent.
The Hill , a newspaper covering congressional news, reports: "Sen. Chuck Grassley (Iowa) is considering leaving his powerful post as senior Republican on the Finance Committee so that he can become the highest-ranking Republican on the Judiciary panel. To avoid a dramatic shake-up, Grassley is hoping to strike a deal…
The FDA expanded approval process for toxic drugs is unaffected by evidence uncovered by the US Justice Department showing the studies to be flawed, if not fraudulent.
Two prominent academic-psychiatrists–Jeffrey Bostic MD, director of school psychiatry, Harvard-Massachusetts General Hospital, and Charles Nemeroff MD, the former chairman of psychiatry at Emory–are featured in current government investigations.
"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD
